Doxycycline Mouthwash for COVID-19 Prevention

← USPTO Patent Applications

PREVENTATIVE MOUTHWASH CONTAINING DOXYCYCLINE AND METHOD OF PREVENTING COVID INFECTION USING THE PREVENTATIVE MOUTHWASH

Application US20260091045A1 Kind: A1 Apr 02, 2026

Inventors

Bruce Roseman

Abstract

A preventative mouthwash includes doxycycline as an active ingredient, and sufficient solvent (such as purified water) to dissolve an antimicrobial oral dosage of the doxycycline into a gargling dosage of the mouthwash. The antimicrobial oral dosage may be at least 100 milligrams (mg) of the doxycycline (such as 400 mg). The gargling dosage may be between 5 milliliters (mL) and 20 mL of the mouthwash (such as 5 mL). The mouthwash may further include a flavoring agent (such as benzaldehyde) to improve taste. A method of preventing COVID infection includes gargling the preventative mouthwash, and repeating the gargling twice a day (such as every 12 hours) for several (such as between 5 and 10, like 7) consecutive days. A method of formulating the preventative mouthwash includes dissolving doxycycline hyclate in purified water to create a liquid solution, and dissolving a flavoring agent in the liquid solution to create the mouthwash.

CPC Classifications

A61K 31/65 A61K 9/006

Filing Date

2024-10-02

Application No.

18904100

View original document →